NEW BIOACTIVE NATURAL PRODUCTS FROM FRESHWATER FUNGI

来自淡水真菌的新型生物活性天然产品

基本信息

  • 批准号:
    6039025
  • 负责人:
  • 金额:
    $ 32.34万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2000
  • 资助国家:
    美国
  • 起止时间:
    2000-02-01 至 2003-01-31
  • 项目状态:
    已结题

项目摘要

This application requests support for an investigation of the natural products chemistry of freshwater filamentous fungi. These rarely-studied fungi are ecologically, morphologically, and taxonomically distinctive, and they commonly display antagonistic effects against other fungi. Like our previous and productive chemical studies of sclerotial and coprophilous fungi, this investigation will employ a systematic, ecology-based approach to organism selection that represents a departure from traditional random microbial screening programs. Based on the propensity of these fungi to show antagonistic effects toward other fungi, together with the increasingly urgent need for new treatments to fight opportunistic fungal infections in humans, efforts will focus on a search for new metabolites with antifungal effects. However, pure compounds will also be tested for other activities through arrangements with a major pharmaceutical company, and by submission to the NCI's antitumor screens. The proposed work involves a collaboration between the PI's group and that of Prof. Carol Shearer, one of the world's foremost experts in aquatic mycology. Preliminary studies of selected aquatic isolates have already afforded 37 new bioactive agents, including some with unusual structures. These initial results provide evidence that this unique, virtually unexplored group of fungi shows considerable promise as a source of novel bioactive natural products, and clearly demonstrate the ability of the research team to perform the proposed studies. Many isolates that exhibit antifungal effects in direct competition assays are available for immediate investigation, and there are no literature reports of prior chemical studies of any of these organisms. Fungal isolates will be cultivated under both liquid and solid-substrate growth conditions, and extracts from these cultures will be subjected to antifungal assays to prioritize cultures for chemical study. Active components will be isolated through bioassay-guided fractionation, and their structures will be determined using spectroscopic methods. While chemical studies progress, further freshwater species will be isolated, identified, and screened for antifungal activity, thereby providing a continuing stream of new isolates for investigation.
本申请请求支持淡水丝状真菌天然产物化学的研究。这些很少被研究的真菌在生态学、形态学和分类学上都是独特的,它们通常对其他真菌表现出拮抗作用。 就像我们以前对菌核和粪生真菌进行的富有成效的化学研究一样,这项调查将采用一种系统的、基于生态学的方法来进行生物体选择,这代表了对传统随机微生物筛选程序的背离。 基于这些真菌对其他真菌表现出拮抗作用的倾向,以及对新治疗方法的日益迫切的需求,以对抗人类机会性真菌感染,努力将集中在寻找具有抗真菌作用的新代谢物上。然而,纯化合物也将通过与一家大型制药公司的安排进行其他活性测试,并提交给NCI的抗肿瘤筛选。 拟议的工作涉及PI小组与世界上最重要的水生真菌学专家之一Carol Shearer教授的合作。 对选定的水生分离物的初步研究已经提供了37种新的生物活性剂,包括一些具有不寻常结构的生物活性剂。 这些初步结果提供了证据,表明这种独特的,几乎未被探索的真菌群作为新型生物活性天然产物的来源显示出相当大的前景,并清楚地表明研究团队有能力进行拟议的研究。 许多在直接竞争试验中表现出抗真菌作用的分离株可用于立即调查,并且没有任何这些生物体的先前化学研究的文献报告。 将在液体和固体基质生长条件下培养真菌分离株,并对这些培养物的提取物进行抗真菌试验,以确定用于化学研究的培养物的优先顺序。 活性成分将通过生物测定指导的分馏分离,并使用光谱方法确定其结构。 随着化学研究的进展,将进一步分离、鉴定和筛选淡水物种的抗真菌活性,从而为研究提供源源不断的新分离株。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAMES B GLOER其他文献

JAMES B GLOER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAMES B GLOER', 18)}}的其他基金

Acquisition of a 600-MHz Nuclear Magnetic Resonance Spectrometer
购置 600 MHz 核磁共振波谱仪
  • 批准号:
    7591580
  • 财政年份:
    2009
  • 资助金额:
    $ 32.34万
  • 项目类别:
Acquisition of a Q-TOF Mass Spectrometer
购买 Q-TOF 质谱仪
  • 批准号:
    7211166
  • 财政年份:
    2007
  • 资助金额:
    $ 32.34万
  • 项目类别:
New Biologically Active Natural Products from Fungi
来自真菌的新型生物活性天然产物
  • 批准号:
    6990586
  • 财政年份:
    2000
  • 资助金额:
    $ 32.34万
  • 项目类别:
New Biologically Active Natural Products from Fungi
来自真菌的新型生物活性天然产物
  • 批准号:
    6872537
  • 财政年份:
    2000
  • 资助金额:
    $ 32.34万
  • 项目类别:
NEW BIOACTIVE NATURAL PRODUCTS FROM FRESHWATER FUNGI
来自淡水真菌的新型生物活性天然产品
  • 批准号:
    6498732
  • 财政年份:
    2000
  • 资助金额:
    $ 32.34万
  • 项目类别:
NEW BIOACTIVE NATURAL PRODUCTS FROM FRESHWATER FUNGI
来自淡水真菌的新型生物活性天然产品
  • 批准号:
    6351341
  • 财政年份:
    2000
  • 资助金额:
    $ 32.34万
  • 项目类别:
New Biologically Active Natural Products from Fungi
来自真菌的新型生物活性天然产物
  • 批准号:
    7154085
  • 财政年份:
    2000
  • 资助金额:
    $ 32.34万
  • 项目类别:
PURCHASE OF AN LC/MS/MS INSTRUMENT
购买 LC/MS/MS 仪器
  • 批准号:
    2791803
  • 财政年份:
    1999
  • 资助金额:
    $ 32.34万
  • 项目类别:
COPROPHILOUS FUNGI--NEW SOURCES OF BIOACTIVE METABOLITES
粪菌--生物活性代谢物的新来源
  • 批准号:
    2063850
  • 财政年份:
    1990
  • 资助金额:
    $ 32.34万
  • 项目类别:
NEW ANTITUMOR AND ANTIFUNGAL NATURAL PRODUCTS FROM FUNGI
来自真菌的新型抗肿瘤和抗真菌天然产品
  • 批准号:
    2084100
  • 财政年份:
    1990
  • 资助金额:
    $ 32.34万
  • 项目类别:

相似海外基金

Extending the utility and durability of antifungal agents via innovative treatment regimens that minimise drug resistance
通过创新治疗方案最大限度地减少耐药性,延长抗真菌药物的效用和持久性
  • 批准号:
    MR/Y002164/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.34万
  • 项目类别:
    Research Grant
Engineering microbial cell factories for production of improved polyene antifungal agents
工程微生物细胞工厂用于生产改进的多烯抗真菌剂
  • 批准号:
    2898887
  • 财政年份:
    2023
  • 资助金额:
    $ 32.34万
  • 项目类别:
    Studentship
Morphological profiling for the development of antifungal agents
用于开发抗真菌药物的形态分析
  • 批准号:
    22H02216
  • 财政年份:
    2022
  • 资助金额:
    $ 32.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
An efficient approach to find therapeutically effective antifungal agents
寻找治疗有效的抗真菌药物的有效方法
  • 批准号:
    22K05337
  • 财政年份:
    2022
  • 资助金额:
    $ 32.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating light-activated therapeutic compounds as antifungal agents.
研究光激活治疗化合物作为抗真菌剂。
  • 批准号:
    2753345
  • 财政年份:
    2022
  • 资助金额:
    $ 32.34万
  • 项目类别:
    Studentship
Discovery of novel therapeutic agents for biliary tract and pancreatic cancer based on antifungal agents
基于抗真菌药物的胆道癌和胰腺癌新型治疗药物的发现
  • 批准号:
    20H03533
  • 财政年份:
    2020
  • 资助金额:
    $ 32.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of antifungal agents that target essential protein kinases in A. fumigatus.
开发针对烟曲霉必需蛋白激酶的抗真菌剂。
  • 批准号:
    2456629
  • 财政年份:
    2020
  • 资助金额:
    $ 32.34万
  • 项目类别:
    Studentship
Development of Broad Spectrum Antifungal Agents
广谱抗真菌药物的开发
  • 批准号:
    9909111
  • 财政年份:
    2020
  • 资助金额:
    $ 32.34万
  • 项目类别:
Elucidation of tip growth factor of fungi and construction of screeing system for antifungal agents
真菌尖端生长因子的阐明及抗真菌药物筛选体系的构建
  • 批准号:
    19K05738
  • 财政年份:
    2019
  • 资助金额:
    $ 32.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Ambruticins: An inspiration to develop novel biocatalysts and antifungal agents
Ambruticins:开发新型生物催化剂和抗真菌剂的灵感
  • 批准号:
    2107517
  • 财政年份:
    2018
  • 资助金额:
    $ 32.34万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了